Benign prostatic hyperplasia.
Insight into the dysfunctional physiology of benign prostatic hyperplasia has expanded appropriate therapies. As the proportion of the population to whom BPH will be a problem increases our attention is directed to evolution in clinical management.
Kuritzky
L
L
Department of Community Health & Family Medicine, University of Florida, Gainesville, USA.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000175:diagnosis / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy
D000317:Adrenergic alpha-Antagonists